These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Phencyclidine-like behavioral effects in pigeons induced by systemic administration of the excitatory amino acid antagonist, 2-amino-5-phosphonovalerate. Koek W; Woods JH; Ornstein P Life Sci; 1986 Sep; 39(11):973-8. PubMed ID: 2875374 [TBL] [Abstract][Full Text] [Related]
3. Turning behavior induced by phencyclidine: relationship to antagonism of N-methyl-D-aspartate in the rat striatum. Johnson KM; Snell LD NIDA Res Monogr; 1986; 67():235-41. PubMed ID: 3092071 [No Abstract] [Full Text] [Related]
4. Both competitive and non-competitive antagonists of N-methyl-D-aspartic acid disrupt brightness discrimination in rats. Tang AH; Ho PM Eur J Pharmacol; 1988 Jun; 151(1):143-6. PubMed ID: 3046954 [TBL] [Abstract][Full Text] [Related]
5. The discriminative stimulus effects of N-methyl-D-aspartate antagonists in phencyclidine-trained rats. Willetts J; Balster RL Neuropharmacology; 1988 Dec; 27(12):1249-56. PubMed ID: 3072489 [TBL] [Abstract][Full Text] [Related]
6. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Marrannes R; Willems R; De Prins E; Wauquier A Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364 [TBL] [Abstract][Full Text] [Related]
7. Selective depression of the segmental polysynaptic reflex by phencyclidine and its analogs in the rat in vitro: interaction with N-methyl-D-aspartate receptors. Ohno Y; Warnick JE J Pharmacol Exp Ther; 1990 Jan; 252(1):246-52. PubMed ID: 1967645 [TBL] [Abstract][Full Text] [Related]
8. Excitatory neurotransmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine in rats: effects of intranigral 2-amino-7-phosphonoheptanoate and N-methyl-D-aspartate. Turski L; Cavalheiro EA; Turski WA; Meldrum BS Neuroscience; 1986 May; 18(1):61-77. PubMed ID: 3016600 [TBL] [Abstract][Full Text] [Related]
9. Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. Wieloch T Science; 1985 Nov; 230(4726):681-3. PubMed ID: 2996146 [TBL] [Abstract][Full Text] [Related]
10. A unified approach to systematic isosteric substitution for acidic groups and application to NMDA antagonists related to 2-amino-7-phosphonoheptanoate. Chenard BL; Lipinski CA; Dominy BW; Mena EE; Ronau RT; Butterfield GC; Marinovic LC; Pagnozzi M; Butler TW; Tsang T J Med Chem; 1990 Mar; 33(3):1077-83. PubMed ID: 2155321 [TBL] [Abstract][Full Text] [Related]
11. Phencyclidine selectively blocks a spinal action of N-methyl-D-aspartate in mice. Aanonsen LM; Wilcox GL Neurosci Lett; 1986 Jun; 67(2):191-7. PubMed ID: 2425302 [TBL] [Abstract][Full Text] [Related]
12. Drug discrimination based on the competitive N-methyl-D-aspartate antagonist, NPC 12626. Willetts J; Bobelis DJ; Balster RL Psychopharmacology (Berl); 1989; 99(4):458-62. PubMed ID: 2687923 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release by phencyclidine is dependent on potassium concentration. Snell LD; Jones SM; Johnson KM Neurosci Lett; 1987 Aug; 78(3):333-7. PubMed ID: 2888064 [TBL] [Abstract][Full Text] [Related]
14. Effect of NMDA and 2-amino-7-phosphonoheptanoate focal injection into the ventrolateral thalamic nucleus on the high pressure neurological syndrome in the rat. Millan MH; Wardley-Smith B; Halsey MJ; Meldrum BS Brain Res; 1990 Jan; 507(2):354-6. PubMed ID: 2159822 [TBL] [Abstract][Full Text] [Related]
15. The NMDA receptor: central role in pain inhibition in rat periaqueductal gray. Jacquet YF Eur J Pharmacol; 1988 Sep; 154(3):271-6. PubMed ID: 2853058 [TBL] [Abstract][Full Text] [Related]
16. The relative potencies of (-)-2-amino-5-phosphonovalerate and (-)-2-amino-7-phosphonoheptanoate as antagonists of N-methylaspartate and quinolinic acids and repetitive spikes in rat hippocampal slices. Stone TW Brain Res; 1986 Aug; 381(1):195-8. PubMed ID: 2875764 [TBL] [Abstract][Full Text] [Related]
17. The specific NMDA receptor antagonist AP-7 attenuates focal ischemic brain injury. Roman R; Bartkowski H; Simon R Neurosci Lett; 1989 Sep; 104(1-2):19-24. PubMed ID: 2554220 [TBL] [Abstract][Full Text] [Related]
19. Long-term development of selective neuronal loss and the mechanism of protection by 2-amino-7-phosphonoheptanoate in a rat model of incomplete forebrain ischaemia. Swan JH; Evans MC; Meldrum BS J Cereb Blood Flow Metab; 1988 Feb; 8(1):64-78. PubMed ID: 2828386 [TBL] [Abstract][Full Text] [Related]
20. Continuously infused 2-amino-7-phosphonoheptanoic acid antagonizes N-methyl-D-aspartate-induced elevations of cyclic GMP in vivo in multiple brain areas and chemically-induced seizure activity. McCaslin PP; Morgan WW Neuropharmacology; 1986 Aug; 25(8):905-9. PubMed ID: 2877414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]